Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms
Clinical trial NCT05127174 · TERMINATED
Trial details
- NCT number
- NCT05127174
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2025-01-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.